A comprehensive view of Prescription Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
AstraZeneca partners with Kazakhstan’s Ministry of Healthcare to contribute to development of Kazakhstan’s pharmaceutical industry; plan includes call to stimulate contract manufacturing of medicines at Kazakh production facilities
Published:
February 08, 2023
by Trend News Agency (Azerbaijan)
|
FDA ends positive test requirement to prescribe Paxlovid COVID-19 treatment to adult and pediatric patients, Lagevrio to adults at risk of progressing to severe COVID-19; FDA still recommends using SARS-CoV-2 viral testing to diagnose COVID-19
Published:
February 08, 2023
by The American Hospital Association (AHA)
|
Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
Published:
February 03, 2023
by GlobeNewswire
|
Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
Published:
February 02, 2023
by Business Wire
|
Amgen Launches Amjevita, a biosimilar to AbbVie's Humira adalimumab, in US to treat seven inflammatory diseases including moderate-to-severe rheumatoid arthritis in adults; Amjevita’s wholesale acquisition cost is 55% below current Humira list price
Published:
February 02, 2023
by Mondaq Business Briefing
|
Ask us about our Consumer Wellness market view
Trending Chart
Interactive chart with headline count